IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing

Core Points - IM Cannabis Corp. has agreed to reduce the exercise price of its November 2024 Warrants from C$4.32 to C$3.43 and extend their expiration date from November 12, 2026, to July 31, 2030 [1] - The company has filed a resale registration statement with the SEC for an aggregate of 4,982,517 common shares, which includes shares from various warrants and options [3][4] - The transaction involving the reduction and extension of the warrants was approved by the independent members of the board of directors [8] Company Overview - IM Cannabis Corp. is a leading medical cannabis company operating in Israel and Germany, focusing on providing premium cannabis products to medical patients [22] - The company leverages a data-driven approach and a globally sourced product supply chain to enhance its commercial and brand power [22] - IM Cannabis operates through subsidiaries in Israel, importing and distributing cannabis, and also runs medical cannabis retail pharmacies and distribution centers [23]